Inhomogeneous Fréedericksz transition in nematic liquid crystals.

Phys Rev E Stat Nonlin Soft Matter Phys

Institut Non Linéaire de Nice, UMR 6618 CNRS-UNSA, 1361 Route des Lucioles, F-06560 Valbonne, France.

Published: January 2002

A theoretical and experimental analysis of a spatial instability developing in a homeotropically aligned nematic liquid crystal film is presented. The explanation for the existence of this instability is supplied through an amplitude equation. This model, which is valid in the vicinity of the Fréedericksz transition, assumes a strong difference between the nematic elastic constants. The first report of such an instability observed in the conditions accounted for by our model, was provided by Cladis and Torza [J. Appl. Phys. 6, 584 (1975)]. We repeated these experiments in order to confirm the validity of the model. Although carried out far from the Fréedericksz transition, these latter show a good qualitative agreement with the theoretical predictions. The nonlinear analysis allows to understand the dynamical behavior of an interface separating domains of stripes through the occurrence of a zigzag instability.

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevE.65.011708DOI Listing

Publication Analysis

Top Keywords

fréedericksz transition
12
nematic liquid
8
inhomogeneous fréedericksz
4
transition nematic
4
liquid crystals
4
crystals theoretical
4
theoretical experimental
4
experimental analysis
4
analysis spatial
4
instability
4

Similar Publications

Purpose: Nano-drug delivery systems (NDDS) have become a promising alternative and adjunctive strategy for lung cancer (LC) treatment. However, comprehensive bibliometric analyses examining global research efforts on NDDS in LC are scarce. This study aims to fill this gap by identifying key research trends, emerging hotspots, and collaboration networks within the field of NDDS and LC.

View Article and Find Full Text PDF

Radical covalent organic frameworks (RCOFs) have demonstrated significant potential in redox catalysis and energy conversion applications. However, the synthesis of stable RCOFs with well-defined neutral carbon radical centers is challenging due to the inherent radical instability, limited synthetic methods and characterization difficulties. Building upon the understanding of stable carbon radicals and structural modulations for preparing crystalline COFs, herein we report the synthesis of a crystalline carbon-centered RCOF through a facile post-oxidation process.

View Article and Find Full Text PDF

TP53 mutations and MDM2 polymorphisms in breast and ovarian cancers: amelioration by drugs and natural compounds.

Clin Transl Oncol

January 2025

Inflammation and Cancer Biology Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam, 784028, India.

Globally, breast and ovarian cancers are major health concerns in women and account for significantly high cancer-related mortality rates. Dysregulations and mutations in genes like TP53, BRCA1/2, KRAS and PTEN increase susceptibility towards cancer. Here, we discuss the impact of mutations in the key regulatory gene, TP53 and polymorphisms in its negative regulator MDM2 which are reported to accelerate cancer progression.

View Article and Find Full Text PDF

Lipid nanoparticles formed with copolymers are a new and increasingly powerful tool for studying membrane proteins, but the extent to which these systems affect the physical properties of the membrane is not completely understood. This is critical to understanding the caveats of these new systems and screening for structural and functional artifacts that might be caused in the membrane proteins they are used to study. To better understand these potential effects, the fluid properties of dipalmitoylphosphatidylcholine lipid bilayers were examined by electron paramagnetic resonance (EPR) spectroscopy with spin-labeled reporter lipids in either liposomes or incorporated into nanoparticles with the copolymers diisobutylene-maleic acid or styrene maleic acid.

View Article and Find Full Text PDF

The global changes from 2001 that elevated substantially modified cell therapies to the definition of "medicinal product" have been the catalyst for the dramatic expansion of the field to its current and future commercial success. Europe was the first to incorporate human somatic cells into drug legislation with the medicines directive of 2001 (2001/83/EC), which led to the development of the term "advanced therapy medicinal products" (ATMPs) to cover all substantially modified products, tissue-engineered products and somatic cells that are not substantially modified but that are used non-homologously. For convenience, I use the term "ATMPs" throughout this review.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!